Feb 284 min readPress ReleaseRubix LS Partners With BioMark To Advance Blood-Based Cancer ScreeningsVancouver, British Columbia – (February 28, 2024) - BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS:...
Jan 234 min readPutting Patients First: Rubix Life Sciences' Guide to Patient-Centric Regulatory ComplianceRegulatory compliance is a crucial aspect of clinical research. And more so in multicultural trials. In this article, we will address...
Dec 20, 202311 min readClinical trial diversity: the drug developer’s guide in 2024How to have quality data and high chances of market success Going after diversity in clinical trials may not sound like the highest ROI...